Trials / Completed
CompletedNCT04664920
An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- Davy Vancampfort · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the usability of a newly designed and developed user-centered exergame in older adults with major neurocognitive disorder (dementia).
Detailed description
The aim of this study is to investigate the usability of a newly designed and developed user-centered exergame in older adults with major neurocognitive disorder (dementia). On one appointment, the participants will perform a user-centered exergame for about 30 minutes. The exergame will include specific cognitive and motor functions. As the difficulty of the training game is user-centered, the participants will always be challenged on an appropriate level. Stepping exercises will be used to control the video game scenario. The video game scenario will include different cognitive functions. The body movements will include different physical aspects including balance, strength and Pelvic Floor Muscle Training (PFMT). During the exergame performance, different qualitative assessments will be performed to determine usability of the exergame including acceptance and game experience protocol (think aloud method). After the exergame performance, the participant will answer individual and guideline-based interview questions about usability including their individual experiences (duration about 20 min). This study contributes to fundamental research investigating how user-centered exergame training can be applied in older adults with individual needs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | exergame | motor-cognitive training device |
Timeline
- Start date
- 2020-06-08
- Primary completion
- 2020-09-25
- Completion
- 2020-09-25
- First posted
- 2020-12-11
- Last updated
- 2020-12-11
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04664920. Inclusion in this directory is not an endorsement.